Draw
|
Currency :
Structure Search
AG003AXG
87333-19-5 | Ramipril
AG003AXG
SDS
COA
Add to Cart
Request For Quotation
- mg
- g
- kg
- ml
- L
无数据
无数据
- mg
- g
- kg
- ml
- L
无数据
| CAS Number | 87333-19-5 |
| Catalog Number | AG003AXG(AGN-PC-0VCFZD) |
| Chemical Name | Ramipril |
| IUPAC Name | (2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid |
| InChI | InChI=1S/C23H32N2O5/c1-3-30-23(29)18(13-12-16-8-5-4-6-9-16)24-15(2)21(26)25-19-11-7-10-17(19)14-20(25)22(27)28/h4-6,8-9,15,17-20,24H,3,7,10-14H2,1-2H3,(H,27,28)/t15-,17-,18-,19-,20-/m0/s1 |
| InChI Key | HDACQVRGBOVJII-JBDAPHQKSA-N |
| MDL Number | MFCD00865775 |
| Molecular Formula | C23H32N2O5 |
| Molecular Weight | 416.5106 |
| NSC Number | 758933 |
| SMILES | C(C)OC(=O)[C@H](CCC1=CC=CC=C1)N[C@H](C(=O)N1[C@@H]2[C@H](C[C@H]1C(=O)O)CCC2)C |
| UNII | L35JN3I7SJ |
| Synonyms | Acovil,
Altace,
Carasel,
Delix,
HOE 498,
HOE-498,
HOE498,
Ramace,
Ramipril,
Triatec,
Tritace,
Vesdil,
Zabien,
ramipril,
87333-19-5,
Tritace,
Altace,
Carasel,
Ramace,
Triatec,
Delix,
Acovil,
Vesdil,
Ramiprilum,
Cardace,
Lostapres,
Hytren,
Quark,
Hoe-498,
Ramiprilum [Latin],
Pramace,
Ramipro,
HOE 498,
Altace (TN),
UNII-L35JN3I7SJ,
MFCD00865775,
CHEMBL1168,
L35JN3I7SJ,
Unipril,
CHEBI:8774,
C23H32N2O5,
(2S,3aS,6aS)-1-((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid, 1-ethyl ester,
(2S,3aS,6aS)-1-((S)-N-((S)-1-Ethoxycarbonyl-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrol-2-carbonsaeure,
(2S,3aS,6aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid,
Naprix,
DSSTox_CID_3551,
DSSTox_RID_77077,
DSSTox_GSID_23551,
(2S,3aS,6aS)-1-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanyl)octahydrocyclopenta[b]pyrrole-2-carboxylic acid,
(2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid,
Cyclopenta(b)pyrrole-2-carboxylic acid, 1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-, (2S-(1(R*(R*)),2alpha,3abeta,6abeta))-,
HOE498,
Hypren,
Ramipril (Altace),
Ramipril [USAN:INN:BAN],
(2S,3aS,6aS)-1-((S)-2-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)octahydrocyclopenta[b]pyrrole-2-carboxylic acid,
(2S,3aS,6aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (non-preferred name),
[2S,3aS,6aS]-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid,
CPD000466386,
SMR000466386,
Pramace (discontinued),
Ramipril (USP/INN),
SR-05000001908,
Prilace,
Ramipril(Altace),
Ramipril [USAN:USP:INN:BAN],
NCGC00016955-01,
(2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid,
CAS-87333-19-5,
AC1NSFPR,
Spectrum_001958,
Spectrum3_001794,
Spectrum4_001269,
Spectrum5_001721,
SCHEMBL16059,
BSPBio_003347,
KBioGR_001858,
KBioSS_002512,
MLS000759523,
MLS001216547,
MLS001423965,
N-(1S-carboethoxy-3-phenylpropyl)-S-alanyl-cis,endo-2-azabicyclo[3.3.0]octane-3S-carboxylic Acid,
BIDD:GT0803,
SPECTRUM1505214,
Ramipro;Tritace;Prilace;Altace,
GTPL6339,
Ramipril, >=98% (HPLC),
DTXSID8023551,
CTK8G2889,
KBio2_002504,
KBio2_005072,
KBio2_007640,
KBio3_002849,
NPD2431,
HDACQVRGBOVJII-JBDAPHQKSA-N,
HMS2051E04,
HMS2090L11,
HMS2093M10,
HMS2231M05,
HMS3259J07,
HMS3715M16,
Pharmakon1600-01505214,
HY-B0279,
ZINC3798757,
Tox21_110708,
BBL033964,
BDBM50084681,
NSC758933,
s1793,
STK801937,
AKOS005622534,
Tox21_110708_1,
AB07503,
AC-1347,
CCG-100833,
CS-2270,
DB00178,
KS-1103,
MCULE-5386328912,
NC00083,
NC00627,
NE42859,
NSC-758933,
NCGC00178127-01,
NCGC00178127-02,
(2s,3as,6as)-1((s)-n-((s)-1-carboxy-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrole-2-carboxylic,
(2S,3aS,6aS)-1-((S)-2-((S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl) octahydrocyclopenta[b]pyrrole-2-carboxylic acid,
(2s,3as,6as)-1-((s)-2-((s)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)-octahydrocyclopenta[b]p,
(2S,3aS,6aS)-1-[(2S)-2-{[(1S)-1-ethoxycarbonyl-3-phenylpropyl]amino}propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid,
(2s,3as,6as)-1-[(s)-2-((s)-1-ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-octahydro-cyclopenta[b],
(2S-(1(R*(R*)),2alpha,3abeta,6abeta))-1-(2-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid,
[2s,3as,6as]-1-[(2s)-2-[[(1s)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopen,
AN-15038,
BC205360,
LS-58199,
SAM001246757,
SAM002699899,
SC-17348,
SBI-0206728.P001,
AB0008490,
AB2000297,
B2208,
D00421,
J90014,
88094-EP2270011A1,
88094-EP2272841A1,
88094-EP2277879A1,
88094-EP2287165A2,
88094-EP2287166A2,
88094-EP2292620A2,
88094-EP2298742A1,
88094-EP2298776A1,
88094-EP2298779A1,
88094-EP2301923A1,
88094-EP2301931A1,
88094-EP2301936A1,
88094-EP2305648A1,
AB00698339-07,
AB00698339-08,
AB00698339_09,
AB00698339_10,
333R195,
SR-05000001908-1,
SR-05000001908-2,
Ramipril, British Pharmacopoeia (BP) Reference Standard,
Ramipril, European Pharmacopoeia (EP) Reference Standard,
Z1946144927,
Ramipril, United States Pharmacopeia (USP) Reference Standard,
Ramipril, Pharmaceutical Secondary Standard; Certified Reference Material,
(2 S ,3 aS ,6 aS )-1[( S )-N-[( S )-1-Carboxy-3-phenylpropyl] alanyl] octahydrocyclopenta [ b ]pyrrole-2-carboxylic acid, 1-ethyl ester,
(2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid,
(2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[d]pyrrole-2-carboxylic acid,
1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-octahydro-cyclopenta[b]pyrrole-2-carboxylic acid(Ramipril),
Cyclopenta(b)pyrrole-2-carboxylic acid, 1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-, (2S(1(R*(R*)),2alpha,3abeta,6abeta))-,
Zabien,
Tritace (TN),
Astra Brand of Ramipril,
Promed Brand of Ramipril,
Aventis Brand of Ramipril,
Hoechst Brand of Ramipril,
Monarch Brand of Ramipril,
Almirall Brand of Ramipril,
D01STB,
Ramipril [USAN:BAN:INN],
AstraZeneca Brand of Ramipril,
Aventis Pharma Brand of Ramipril,
C23-H32-N2-O5,
ACN-048192,
CID5362129,
CS-O-02262,
Ramipro, Tritace, Altace, Prilace, Ramipril,
D017257,
(2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydro-cyclopenta[b]pyrrole-2-carboxylic acid,
(2 S ,3 aS,6 aS)-1[(S)-N-[(S)-1-Carboxy-3-phenylpropyl] alanyl] octahydrocyclopenta [ b ]pyrrole-2-carboxylic acid, 1-ethyl ester,
Cyclopenta[b]pyrrole-2-carboxylic acid, 1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydro-, (2S,3aS,6aS)-,
|
| Complexity | 619 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 5 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 416.231g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 30 |
| Hydrogen Bond Acceptor Count | 6 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 416.518g/mol |
| Monoisotopic Mass | 416.231g/mol |
| Rotatable Bond Count | 10 |
| Topological Polar Surface Area | 95.9A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 1.4 |
GHS Hazard and Precautionary Statements
| Symbol: |  |
| Hazard Class | |
| Hazard statements | H302-H315-H319-H335 |
| Packing Group | |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code |
Certificate of Analysis
Lot Number
Related Research Chemicals
CERTIFICATE OF ANALYSIS
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
Analysis Data:
| Test: | Result: |
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited